NCT06801223 - A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 30, 2025

Primary Completion Date

May 5, 2028

Study Completion Date

May 20, 2028

Conditions

Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)

Interventions

DRUG

Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours)

25mg/kg SUL and 25mg/kg DUR

DRUG

Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours)

20mg/kg SUL and 20mg/kg DUR

DRUG

Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours)

25mg/kg SUL and 25mg/kg DUR

DRUG

Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours)

20mg/kg SUL and 20mg/kg DUR

Trial Locations (4)

RECRUITING

ECU Brody School of Medicine, Greenville

RECRUITING

UCLA Medical Center, Los Angeles

RECRUITING

Rady Children's Hospital, San Diego

RECRUITING

University of Texas Medical Branch at Galveston, Galveston